The use of opioid analgesia in end-stage renal disease patients managed without dialysis: recommendations for practice
FEM Murtagh, MO Chai, P Donohoe… - Journal of pain & …, 2007 - Taylor & Francis
The numbers of patients dying with end-stage renal disease (ESRD), particularly those
managed conservatively (without dialysis) or withdrawing from dialysis is increasing rapidly …
managed conservatively (without dialysis) or withdrawing from dialysis is increasing rapidly …
Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta‐analysis
C Ramsenthaler, P Kane, W Gao… - European journal of …, 2016 - Wiley Online Library
Objectives Multiple myeloma (MM) is an incurable haematological disease. Due to novel
agents, overall survival has improved in this group, yet there are no systematic reviews to …
agents, overall survival has improved in this group, yet there are no systematic reviews to …
What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools
TR Osborne, C Ramsenthaler… - European Journal of …, 2012 - Wiley Online Library
Introduction Treatment advances in multiple myeloma have increased expected survival
from months to years for some patients. Alongside improved survival emerges a need to …
from months to years for some patients. Alongside improved survival emerges a need to …
A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer
P Edmonds, S Karlsen, S Khan… - Palliative …, 2001 - journals.sagepub.com
This paper reports on data from the Regional Study of Care for the Dying, conducted in
1990, and compares symptoms, care and service utilization for patients with chronic lung …
1990, and compares symptoms, care and service utilization for patients with chronic lung …
Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis
FEM Murtagh, JM Addington-Hall… - Journal of palliative …, 2007 - liebertpub.com
Background: Numbers of patients with stage 5 chronic kidney disease (CKD) managed
conservatively (without dialysis) are increasing steadily but prevalence and severity of …
conservatively (without dialysis) are increasing steadily but prevalence and severity of …
The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life
H Elkington, P White, J Addington-Hall… - Palliative …, 2005 - journals.sagepub.com
Chronic obstructive pulmonary disease (COPD) causes almost as many deaths as lung
cancer, yet evidence about the impact of COPD in the latter stages of illness is limited. We …
cancer, yet evidence about the impact of COPD in the latter stages of illness is limited. We …
[HTML][HTML] Characteristics, symptom management, and outcomes of 101 patients with COVID-19 referred for hospital palliative care
N Lovell, M Maddocks, SN Etkind, K Taylor… - Journal of Pain and …, 2020 - Elsevier
Hospital palliative care is an essential part of the COVID-19 response but data are lacking.
We identified symptom burden, management, response to treatment, and outcomes for a …
We identified symptom burden, management, response to treatment, and outcomes for a …
Managing the supportive care needs of those affected by COVID-19
S Bajwah, A Wilcock, R Towers… - European …, 2020 - Eur Respiratory Soc
Globally, the number of people affected by coronavirus disease 2019 (COVID-19) is rapidly
increasing. In most (> 80%), the illness is relatively mild and can be self-managed out of …
increasing. In most (> 80%), the illness is relatively mild and can be self-managed out of …
[HTML][HTML] Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II trial
IJ Higginson, P McCrone, SR Hart, R Burman… - Journal of pain and …, 2009 - Elsevier
CONTEXT: Palliative care is being advocated for noncancer patients but needs evidence of
effectiveness and cost-effectiveness. OBJECTIVE: We evaluated the cost-effectiveness of a …
effectiveness and cost-effectiveness. OBJECTIVE: We evaluated the cost-effectiveness of a …
[HTML][HTML] Symptoms in the month before death for stage 5 chronic kidney disease patients managed without dialysis
FE Murtagh, J Addington-Hall, P Edmonds… - Journal of pain and …, 2010 - Elsevier
CONTEXT: There is little evidence on the symptoms experienced by those with advanced
(Stage 5) chronic kidney disease (CKD), managed without dialysis, as they approach death …
(Stage 5) chronic kidney disease (CKD), managed without dialysis, as they approach death …